Supplementary Table 1. Summary of clinicopathologic characteristics of recurred cases.

Case no.	Group	Age (yr)	Pathology	FIGO stage	Site of recurrence	Duration from surgery (mo)	Treatment modality for recurrence	Current status
1	CRH	43	Adenocarcinoma	IB1	PALN	13	Laparoscopic operation→RT	NED
2	NSRH	45	Adenocarcinoma	IB1	Lung	90	Chemotherapy	NED
3	CRH	51	SCCA	IB1	Lung	15	Resection→chemotherapy	NED
4	NSRH	47	SCCA	IIA	Lung, liver	19	Chemotherapy	DOD
5	NSRH	47	Adenocarcinoma	IB2	Pelvis	38	Pelvic exenteration→RT	Alive with disease
					Lung	47	Resection→chemotherapy

CRH, conventional radical hysterectomy; DOD, death of disease; FIGO, International Federation of Gynecology and Obstetrics; NED, no evidence of disease; NSRH, nerve-sparing radical hysterectomy; PALN, para-aortic lymph node; RT, radiotherapy; SCCA, squamous cell carcinoma.